HANNE CAPITAL
Hanne Capital is a healthcare venture capital fund focusing on growth opportunities in the Greater China.
HANNE CAPITAL
Industry:
Health Care
Founded:
2017-01-01
Status:
Active
Contact:
+86-21-6475-2860
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Azure DNS ASP.NET Alibaba HiChina DNS China Ministry Of Public Security CNZZ Tengine
Similar Organizations
Cherubic Ventures
Founded in 2014, Cherubic Ventures is the only early-stage venture capital firm that's active in both US and the Greater China Area.
Lighthouse Capital Management
Lighthouse Capital Management is an early venture capital fund focusing on the Chinese and US markets.
OTV
OTV is a global digital health venture capital fund with offices in Tel Aviv, Israel and Shanghai
Current Employees Featured
Edward Zhou
Edward Zhou Founder & Managing Partner @ Hanne Capital Founder & Managing Partner 2017-01-01
Founder
Edward Zhou
Stock Details
Company's stock symbol is HKG:02190
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-05-09 | Reistone Biopharma | Hanne Capital investment in Series A - Reistone Biopharma | 100 M USD |
2021-01-08 | KYinno | Hanne Capital investment in Series A - KYinno | 60 M CNY |
2020-10-20 | BioNova Pharma | Hanne Capital investment in Series B - BioNova Pharma | 25 M USD |
2020-09-01 | FRESH WIND GROUP HOLDING LIMITED | Hanne Capital investment in Series A - FRESH WIND GROUP HOLDING LIMITED | 30 M USD |
2020-09-01 | Celula China | Hanne Capital investment in Series B - Celula China | 50 M CNY |
2020-08-31 | IMVAQ Therapeutics | Hanne Capital investment in Series B - IMVAQ Therapeutics | 20 M USD |
2020-06-29 | Biotheus | Hanne Capital investment in Series C - Biotheus | 5 M USD |
2019-12-02 | EOC Pharma Group | Hanne Capital investment in Series C - EOC Pharma Group | 500 M CNY |
2019-09-27 | Ningkang Ruizhu | Hanne Capital investment in Series A - Ningkang Ruizhu | 10 M USD |
2019-08-28 | HiFiBiO | Hanne Capital investment in Series C - HiFiBiO | 67 M USD |